Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2025

Description

List of Tables

GlobalData's clinical trial report, "Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2025" provides an overview of Atopic Dermatitis (Atopic Eczema) Clinical trials scenario. This report provides top line data relating to the clinical trials on Atopic Dermatitis (Atopic Eczema). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Product Code: GDHC7232CTIDB

List of Tables

List of Figures

Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Atopic Dermatitis (Atopic Eczema)
Apr 23, 2025: Aclaris Therapeutics receives FDA approval for Phase Ia/Ib trial of ATI-052
Apr 23, 2025: Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
Apr 22, 2025: Kymera Therapeutics Announces First Patient Dosed in BROADEN Phase 1b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader
Apr 17, 2025: Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader for Inflammatory Conditions
Apr 09, 2025: SinoMab BioScience Breakthrough Phase 1b POC Results for SM17 in Atopic Dermatitis
Apr 08, 2025: Alphyn Announces First Patient Dosed in Clear-AD1 Global Phase 2B Clinical Trial Program of Zabalafin Hydrogel for Atopic Dermatitis
Mar 20, 2025: Domain Therapeutics Discloses DT-9046 as a Groundbreaking Oral Drug Candidate for Inflammatory Diseases
Mar 20, 2025: Sitryx Initiates Phase 1 Clinical Trial of Potential Disease-Modifying Treatment for Atopic Dermatitis SYX-5219
Mar 17, 2025: ZORYVE Cream 0.15% Approved by Health Canada for the Treatment of Mild to Moderate AD in Adults and Children as Young as Six Years of Age
Mar 17, 2025: HK inno.N Moves Topical JAK Inhibitor Into Phase 2 for Atopic Dermatitis
Mar 17, 2025: Evommune Initiates Phase 2 Trial of IL-18 Targeted Fusion Protein, EVO301, in Adult Patients With Atopic Dermatitis
Mar 10, 2025: Hudson Therapeutics, the U.S. Subsidiary of Shaperon, Announces Initiation of Phase 2b Part 2 Clinical Trial for NuGel
Mar 08, 2025: Amgen and Kyowa Kirin Provide Top-Line Results From Rocatinlimab Phase 3 Ignite Study in Adults With Moderate to Severe Atopic Dermatitis
Mar 08, 2025: Organon's VTAMA Phase 3 Data Shows Atopic Dermatitis Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age
Mar 07, 2025: Arcutis To Highlight Data From Phase 3 Trials for Scalp and Body Psoriasis and Atopic Dermatitis at the 83rd American Academy of Dermatology Meeting
Mar 07, 2025: Lilly's Ebglyss Single Monthly Maintenance Injection Achieved Completely Clear Skin at Three Years in Half of Patients With Atopic Dermatitis
Mar 03, 2025: Apogee Therapeutics Announces Positive Interim Phase 1 Results From the APG990 Healthy Volunteer Trial, APG279 (APG777 + APG990)
Feb 28, 2025: Bambusa Therapeutics doses first volunteers in Phase I bispecific AD trial
Feb 28, 2025: Incyte to Unveil New Data from Ruxolitinib at 2025 American Academy of Dermatology (AAD) Annual Meeting
Feb 28, 2025: Apogee to Host Conference Call to Report Results from the Phase 1 Trial for APG990 and Provide Combination Strategy Update on March 3, 2025
Feb 28, 2025: Arcutis to Present Poster On Roflumilast Cream at the 83rd American Academy of Dermatology Annual Meeting
Feb 26, 2025: U.S. FDA Accepts Supplemental NDA for Arcutis' ZORYVE Cream 0.05% for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis
Feb 26, 2025: Kyowa Kirin Announces Late-Breaking Abstract Presentation at the American Academy of Dermatology Annual Meeting 2025
Feb 26, 2025: Derm-Biome's DB-007-5 Is Highly Effective at Treating AD and Reducing Itch in Preclinical Study, Outperforming the Current Leading Topical AD Drug
Feb 24, 2025: Arcutis Announces Publication of Data from INTEGUMENT-PED Trial Evaluating ZORYVE in Children with Atopic Dermatitis in Pediatric Dermatology
Feb 21, 2025: Chime Biologics Supports Mabgeek To Enter the U.S. Phase III Trials for MG-K10
Feb 20, 2025: Astria Therapeutics To Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress
Feb 03, 2025: Apogee Therapeutics Announces First Patient Dosed in Part B of Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis
Clinical Trial Profile Snapshots

Appendix

Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

Product Code: GDHC7232CTIDB

List of Table

List of Tables

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Region, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Europe, Top Five Countries, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, North America, Top Countries, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2025*
Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, G7 Countries (%), 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Phase, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2025*
Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, E7 Countries (%), 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Phase, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Phase, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Phase 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Trial Status, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, by End Point Status, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2020-2024
Atopic Dermatitis (Atopic Eczema) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Key Sponsors, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2025*

List of Figure

List of Figures

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Region (%), 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, North America, Top Countries (%), 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2025*
Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, G7 Countries (%), 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Phase, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2025*
Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, E7 Countries (%), 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Phase, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Phase (%), 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Phase, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Trial Status, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, by End Point Status, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2020-2024
Atopic Dermatitis (Atopic Eczema) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Key Sponsors, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2025*
Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2025*
GlobalData Methodology

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2025

Description

Table of Contents

List of Tables

Scope

Reasons to Buy

Table of Contents

Table of Contents

List of Tables

List of Figures

Appendix

List of Table

List of Tables

List of Figure

List of Figures